| JXSL1600028 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2016-06-15 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-11-23 | view |
| JXSL1600027 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2016-06-15 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-11-23 | view |
| JXSL1600029 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2016-06-15 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-11-23 | view |
| JXSL1600034 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2016-07-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-07-17 | view |
| JXSL1600035 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2016-07-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-07-17 | view |
| JXSL1700077 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2017-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2018-12-04 | view |
| JXSL1700076 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2017-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2018-12-04 | view |
| JXSL1700079 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2017-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2018-12-04 | view |
| JXSL1700078 | Emicizumab注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2017-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2018-12-04 | view |
| JYSB1900130 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
| JYSB1900129 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
| JYSB1900128 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
| JYSB1900131 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
| JYSB1900196 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
| JYSB1900199 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
| JYSB1900198 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
| JYSB1900197 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
| JYSB1900333 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
| JYSB1900336 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
| JYSB1900335 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
